Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-50512.35%
operating margin TTM
-55504.94%
revenue TTM
91.44 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.36 |
| peg ratio | -0.17 |
| price to book ratio | 1.45 |
| price to sales ratio | 687.47 |
| enterprise value multiple | -3.00 |
| price fair value | 1.45 |
profitability ratios | |
|---|---|
| gross profit margin | -645.68% |
| operating profit margin | -55504.94% |
| pretax profit margin | -50512.35% |
| net profit margin | -50512.35% |
| return on assets | -49.83% |
| return on equity | -100.85% |
| return on capital employed | -60.46% |
liquidity ratio | |
|---|---|
| current ratio | 10.25 |
| quick ratio | 10.25 |
| cash ratio | 10.14 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.04 |
| interest coverage | -82.19 |
| cash flow to debt ratio | -20.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.12 |
| cash per share | 2.53 |
| operating cash flow per share | -1.12 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -20.35 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -3,164.64 |
Frequently Asked Questions
When was the last time Actinium Pharmaceuticals, Inc. (AMEX:ATNM) reported earnings?
Actinium Pharmaceuticals, Inc. (ATNM) published its most recent earnings results on 14-11-2024.
What is Actinium Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Actinium Pharmaceuticals, Inc. (AMEX:ATNM)'s trailing twelve months ROE is -100.85%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Actinium Pharmaceuticals, Inc. (ATNM) currently has a ROA of -49.83%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ATNM's net profit margin stand at?
ATNM reported a profit margin of -50512.35% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ATNM's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.25 in the most recent quarter. The quick ratio stood at 10.25, with a Debt/Eq ratio of 0.04.